DexCom (NASDAQ: DXCM) reported Q1 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $71.32 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.